Notice of Intent for BD Flow Cytometry Antibodies Reagents

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), has issued a Pre-Solicitation Notice (NOI-NIAID-25-2258921) regarding a potential sole-source contract for flow cytometry antibodies. The notice specifically involves procuring 28 types of flow cytometry antibodies along with associated shipping and handling costs, to be delivered to Bethesda, MD. The procurement will be conducted under NAICS code 325414 for Biological Product Manufacturing, utilizing the statutory authority of 41 U.S.C. 1901(a)(1) which allows for procurement from only one responsible source. The agency intends to negotiate directly with BD for these specialized laboratory reagents, citing that no other supply or service will satisfy their specific requirements.

Contractors interested in this opportunity are invited to submit capability statements through the NIAID electronic Simplified Acquisition Submission System (eSASS) by April 17, 2025, at 10:00 am. All potential vendors must first register in the eSASS system before submitting documentation, with detailed registration instructions available on the website. While the notice indicates a potential sole-source contract with BD, NIAID is open to receiving documentation from other vendors who believe they can provide comparable consumables. This is explicitly not a formal Request for Proposal, and the government retains full discretion to determine whether to compete the requirement based on the responses received. Vendors should carefully review the submission requirements and understand that this is a pre-solicitation notice meant to gather market information and potential alternative sources for the specified flow cytometry antibodies and related services.